Medigent DIS of DeltaWare Systems, the Canadian business unit of Maximus, offers up-to-date profiles and information for improved health planning, evaluation and research. The Medigent DIS will be
Horizant is XenoPort’s first approved product. Horizant extended-release tablets are indicated for the management of postherpetic neuralgia (PHN) in adults patients. GSK holds commercialization rights and certain development
The results of the trial demonstrated that the DAC HYP showed reduction in annualized relapse rate by 54% when administered subcutaneously once every four weeks in 150mg dose
Bioservative is used to preserve microbiological samples for up to seven days and also delays the breakdown of DNA, RNA and peptides for up to 26 days. Bioservative
Onyx Scientific, a chemistry solutions provider to pharma and biotech companies, will continue to operate out of its Silverbriar facility (Sunderland, UK) under the Onyx Scientific trade name.
In the trial, the patients will smoke X-22 for a duration of six weeks time period with an aim to stop smoking by the end of 6 weeks.
Antares’ net loss was $1.554m, or $0.02 loss per diluted share, compared to net loss of $1.552m, or $0.02 loss per diluted share, for the same period in
CRPL is a subsidiary of TCG Lifesciences, a provider of drug discovery and development research services company. CTA CEO Marcus Clark said they expect that this collaboration will
The agreement allows Proteome to apply its PS Biomarker Services to deliver an elaborated analysis of post-translational modifications on a neurological disease-related protein Proteome is also expected to
The research work is focused to develop stem cell and gene therapies to treat benign and malignant diseases. apceth CEO Christine Gunther said the manufacturer’s licence has been
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.